nodes	percent_of_prediction	percent_of_DWPC	metapath
Rilpivirine—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.644	0.708	CbGbCtD
Rilpivirine—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.266	0.292	CbGbCtD
Rilpivirine—White blood cell count decreased—Riluzole—amyotrophic lateral sclerosis	0.00818	0.093	CcSEcCtD
Rilpivirine—Cholecystitis—Riluzole—amyotrophic lateral sclerosis	0.00709	0.0805	CcSEcCtD
Rilpivirine—Platelet count decreased—Riluzole—amyotrophic lateral sclerosis	0.00684	0.0778	CcSEcCtD
Rilpivirine—Haemoglobin decreased—Riluzole—amyotrophic lateral sclerosis	0.00591	0.0672	CcSEcCtD
Rilpivirine—Nephrolithiasis—Riluzole—amyotrophic lateral sclerosis	0.00506	0.0575	CcSEcCtD
Rilpivirine—Blood bilirubin increased—Riluzole—amyotrophic lateral sclerosis	0.0043	0.0489	CcSEcCtD
Rilpivirine—Abnormal dreams—Riluzole—amyotrophic lateral sclerosis	0.00402	0.0457	CcSEcCtD
Rilpivirine—Aspartate aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00266	0.0302	CcSEcCtD
Rilpivirine—Alanine aminotransferase increased—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0296	CcSEcCtD
Rilpivirine—Abdominal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00245	0.0278	CcSEcCtD
Rilpivirine—Depression—Riluzole—amyotrophic lateral sclerosis	0.00227	0.0258	CcSEcCtD
Rilpivirine—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00215	0.0245	CcSEcCtD
Rilpivirine—Urinary tract disorder—Riluzole—amyotrophic lateral sclerosis	0.00202	0.0229	CcSEcCtD
Rilpivirine—Urethral disorder—Riluzole—amyotrophic lateral sclerosis	0.002	0.0228	CcSEcCtD
Rilpivirine—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00185	0.021	CcSEcCtD
Rilpivirine—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00179	0.0204	CcSEcCtD
Rilpivirine—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.00178	0.0202	CcSEcCtD
Rilpivirine—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00151	0.0172	CcSEcCtD
Rilpivirine—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0015	0.0171	CcSEcCtD
Rilpivirine—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0168	CcSEcCtD
Rilpivirine—Infection—Riluzole—amyotrophic lateral sclerosis	0.00144	0.0164	CcSEcCtD
Rilpivirine—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0162	CcSEcCtD
Rilpivirine—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00141	0.016	CcSEcCtD
Rilpivirine—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0149	CcSEcCtD
Rilpivirine—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00129	0.0147	CcSEcCtD
Rilpivirine—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0143	CcSEcCtD
Rilpivirine—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00125	0.0142	CcSEcCtD
Rilpivirine—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00125	0.0142	CcSEcCtD
Rilpivirine—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00119	0.0135	CcSEcCtD
Rilpivirine—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00115	0.013	CcSEcCtD
Rilpivirine—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00104	0.0118	CcSEcCtD
Rilpivirine—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000993	0.0113	CcSEcCtD
Rilpivirine—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00096	0.0109	CcSEcCtD
Rilpivirine—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000923	0.0105	CcSEcCtD
Rilpivirine—Rash—Riluzole—amyotrophic lateral sclerosis	0.000916	0.0104	CcSEcCtD
Rilpivirine—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000915	0.0104	CcSEcCtD
Rilpivirine—Headache—Riluzole—amyotrophic lateral sclerosis	0.00091	0.0103	CcSEcCtD
Rilpivirine—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000862	0.0098	CcSEcCtD
Rilpivirine—NR1I2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000224	0.0966	CbGpPWpGaD
Rilpivirine—NR1I2—Nuclear Receptors—RARA—amyotrophic lateral sclerosis	0.000205	0.0883	CbGpPWpGaD
Rilpivirine—NR1I2—Nuclear Receptor transcription pathway—RARA—amyotrophic lateral sclerosis	0.000162	0.0698	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—ZNF470—amyotrophic lateral sclerosis	7.02e-05	0.0303	CbGpPWpGaD
Rilpivirine—CYP2C19—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	6e-05	0.0259	CbGpPWpGaD
Rilpivirine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	5.7e-05	0.0246	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—ZNF746—amyotrophic lateral sclerosis	5.32e-05	0.023	CbGpPWpGaD
Rilpivirine—CYP1A2—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	4.67e-05	0.0202	CbGpPWpGaD
Rilpivirine—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	4.2e-05	0.0181	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—ZNF470—amyotrophic lateral sclerosis	3.38e-05	0.0146	CbGpPWpGaD
Rilpivirine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	3.35e-05	0.0145	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—SMN1—amyotrophic lateral sclerosis	2.87e-05	0.0124	CbGpPWpGaD
Rilpivirine—NR1I2—Generic Transcription Pathway—RARA—amyotrophic lateral sclerosis	2.79e-05	0.0121	CbGpPWpGaD
Rilpivirine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	2.59e-05	0.0112	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—ZNF746—amyotrophic lateral sclerosis	2.56e-05	0.0111	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	2.5e-05	0.0108	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	2.28e-05	0.00985	CbGpPWpGaD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	2.28e-05	0.00984	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	2.12e-05	0.00916	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	2e-05	0.00861	CbGpPWpGaD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	1.94e-05	0.00837	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	1.8e-05	0.00776	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—HNRNPA1—amyotrophic lateral sclerosis	1.78e-05	0.00766	CbGpPWpGaD
Rilpivirine—SLCO1B3—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	1.73e-05	0.00746	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	1.68e-05	0.00724	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—FUS—amyotrophic lateral sclerosis	1.65e-05	0.00712	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—EXOSC9—amyotrophic lateral sclerosis	1.6e-05	0.0069	CbGpPWpGaD
Rilpivirine—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	1.57e-05	0.00678	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	1.53e-05	0.00662	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	1.53e-05	0.00661	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	1.48e-05	0.00638	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	1.43e-05	0.00615	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	1.37e-05	0.0059	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	1.35e-05	0.00581	CbGpPWpGaD
Rilpivirine—NR1I2—Gene Expression—RARA—amyotrophic lateral sclerosis	1.35e-05	0.00581	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	1.34e-05	0.00579	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	1.3e-05	0.00562	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	1.3e-05	0.00559	CbGpPWpGaD
Rilpivirine—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.23e-05	0.00533	CbGpPWpGaD
Rilpivirine—CYP1A2—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	1.22e-05	0.00528	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	1.21e-05	0.00521	CbGpPWpGaD
Rilpivirine—SLCO1B1—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	1.16e-05	0.00501	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	1.16e-05	0.005	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	1.12e-05	0.00483	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	1.12e-05	0.00482	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—TPK1—amyotrophic lateral sclerosis	1.11e-05	0.0048	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—VAPB—amyotrophic lateral sclerosis	1.11e-05	0.0048	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	1.06e-05	0.00456	CbGpPWpGaD
Rilpivirine—ABCG2—Fluoropyrimidine Activity—TP53—amyotrophic lateral sclerosis	1.04e-05	0.0045	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	1.04e-05	0.00448	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	1.04e-05	0.00447	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—VAPA—amyotrophic lateral sclerosis	1.02e-05	0.00439	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	9.85e-06	0.00425	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	9.85e-06	0.00425	CbGpPWpGaD
Rilpivirine—CYP1A2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.62e-06	0.00415	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—SACM1L—amyotrophic lateral sclerosis	9.45e-06	0.00408	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	9.19e-06	0.00397	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—FIG4—amyotrophic lateral sclerosis	8.89e-06	0.00383	CbGpPWpGaD
Rilpivirine—SLCO1B3—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.78e-06	0.00379	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	8.7e-06	0.00376	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	8.6e-06	0.00371	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	8.35e-06	0.00361	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—DAO—amyotrophic lateral sclerosis	8.04e-06	0.00347	CbGpPWpGaD
Rilpivirine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	7.92e-06	0.00342	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	7.87e-06	0.00339	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.79e-06	0.00336	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	7.47e-06	0.00322	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	7.47e-06	0.00322	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	7.38e-06	0.00319	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	7.31e-06	0.00316	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	7.26e-06	0.00313	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.21e-06	0.00311	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	7.05e-06	0.00304	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.96e-06	0.00301	CbGpPWpGaD
Rilpivirine—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	6.96e-06	0.003	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	6.91e-06	0.00298	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	6.91e-06	0.00298	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.88e-06	0.00297	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	6.83e-06	0.00295	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	6.72e-06	0.0029	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	6.7e-06	0.00289	CbGpPWpGaD
Rilpivirine—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	6.66e-06	0.00287	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	6.63e-06	0.00286	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.62e-06	0.00286	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.62e-06	0.00286	CbGpPWpGaD
Rilpivirine—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	6.61e-06	0.00285	CbGpPWpGaD
Rilpivirine—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	6.52e-06	0.00282	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.35e-06	0.00274	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	6.32e-06	0.00273	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.13e-06	0.00265	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.13e-06	0.00265	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	6.13e-06	0.00265	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PLB1—amyotrophic lateral sclerosis	6.09e-06	0.00263	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	6.05e-06	0.00261	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	5.97e-06	0.00258	CbGpPWpGaD
Rilpivirine—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.9e-06	0.00255	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.88e-06	0.00254	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	5.8e-06	0.0025	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.7e-06	0.00246	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GSR—amyotrophic lateral sclerosis	5.62e-06	0.00243	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	5.53e-06	0.00239	CbGpPWpGaD
Rilpivirine—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.46e-06	0.00236	CbGpPWpGaD
Rilpivirine—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.42e-06	0.00234	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	5.4e-06	0.00233	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.36e-06	0.00231	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	5.12e-06	0.00221	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	5.12e-06	0.00221	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	5.07e-06	0.00219	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	5.07e-06	0.00219	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	5e-06	0.00216	CbGpPWpGaD
Rilpivirine—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5e-06	0.00216	CbGpPWpGaD
Rilpivirine—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.93e-06	0.00213	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.71e-06	0.00203	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	4.64e-06	0.002	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—CHAT—amyotrophic lateral sclerosis	4.62e-06	0.00199	CbGpPWpGaD
Rilpivirine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	4.56e-06	0.00197	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	4.37e-06	0.00189	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	4.32e-06	0.00186	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.31e-06	0.00186	CbGpPWpGaD
Rilpivirine—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	4.28e-06	0.00185	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	4.21e-06	0.00182	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	4.12e-06	0.00178	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.09e-06	0.00177	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	4.05e-06	0.00175	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.9e-06	0.00168	CbGpPWpGaD
Rilpivirine—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.89e-06	0.00168	CbGpPWpGaD
Rilpivirine—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.84e-06	0.00166	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	3.83e-06	0.00165	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	3.83e-06	0.00165	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.79e-06	0.00164	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	3.78e-06	0.00163	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.74e-06	0.00161	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.74e-06	0.00161	CbGpPWpGaD
Rilpivirine—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	3.71e-06	0.0016	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.67e-06	0.00158	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	3.66e-06	0.00158	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.57e-06	0.00154	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	3.5e-06	0.00151	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	3.5e-06	0.00151	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.44e-06	0.00148	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.42e-06	0.00148	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.31e-06	0.00143	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.31e-06	0.00143	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.26e-06	0.00141	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.18e-06	0.00137	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.1e-06	0.00134	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	3.06e-06	0.00132	CbGpPWpGaD
Rilpivirine—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.01e-06	0.0013	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.99e-06	0.00129	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.98e-06	0.00129	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.98e-06	0.00129	CbGpPWpGaD
Rilpivirine—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.96e-06	0.00128	CbGpPWpGaD
Rilpivirine—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.95e-06	0.00127	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.89e-06	0.00125	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.87e-06	0.00124	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.83e-06	0.00122	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.8e-06	0.00121	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.78e-06	0.0012	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.78e-06	0.0012	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2.77e-06	0.0012	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.73e-06	0.00118	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	2.7e-06	0.00117	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	2.56e-06	0.00111	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.54e-06	0.0011	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.48e-06	0.00107	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.39e-06	0.00103	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	2.32e-06	0.001	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	2.3e-06	0.000994	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	2.3e-06	0.000994	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.28e-06	0.000984	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	2.16e-06	0.000931	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.16e-06	0.000931	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	2.11e-06	0.000909	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	2.1e-06	0.000908	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	2.1e-06	0.000906	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.05e-06	0.000884	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.96e-06	0.000845	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.94e-06	0.000837	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.94e-06	0.000836	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.89e-06	0.000816	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—APOE—amyotrophic lateral sclerosis	1.88e-06	0.000809	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.84e-06	0.000795	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.83e-06	0.00079	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.76e-06	0.000761	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.67e-06	0.000719	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.67e-06	0.000719	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.64e-06	0.000706	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.59e-06	0.000686	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.55e-06	0.00067	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.54e-06	0.000666	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.53e-06	0.000661	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.51e-06	0.000651	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.45e-06	0.000626	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.42e-06	0.000612	CbGpPWpGaD
Rilpivirine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.38e-06	0.000597	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.37e-06	0.000593	CbGpPWpGaD
Rilpivirine—SLCO1B3—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.29e-06	0.000555	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.26e-06	0.000545	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	1.26e-06	0.000544	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.24e-06	0.000535	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	1.17e-06	0.000504	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.16e-06	0.000503	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.13e-06	0.000488	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.13e-06	0.000488	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.04e-06	0.000449	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.94e-07	0.000429	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	9.56e-07	0.000413	CbGpPWpGaD
Rilpivirine—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.63e-07	0.000373	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	8.55e-07	0.000369	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.55e-07	0.000369	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.34e-07	0.00036	CbGpPWpGaD
Rilpivirine—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	7.99e-07	0.000345	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.85e-07	0.000339	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.75e-07	0.000334	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.67e-07	0.000331	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.66e-07	0.000287	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	6.46e-07	0.000279	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	6.31e-07	0.000272	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.12e-07	0.000264	CbGpPWpGaD
Rilpivirine—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.86e-07	0.000253	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.14e-07	0.000222	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	5.04e-07	0.000217	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.72e-07	0.000204	CbGpPWpGaD
Rilpivirine—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.43e-07	0.000191	CbGpPWpGaD
Rilpivirine—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.32e-07	0.000187	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.89e-07	0.000168	CbGpPWpGaD
Rilpivirine—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.45e-07	0.000149	CbGpPWpGaD
Rilpivirine—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.66e-07	0.000115	CbGpPWpGaD
